Get started
RocketTickers

Alnylam Reports Positive Topline Results from ILLUMINATE-C Phase

Long
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)  
RocketTickers  
NASDAQ:ALNY   Alnylam Pharmaceuticals, Inc.
Beyond Technical Analysis
0
0
beyondta
ALNY: Alnylam Pharmaceuticals, Inc.
2021-07-29 07:00:00
Alnylam Reports Positive Topline Results from ILLUMINATE-C Phase 3 Study of Lumasiran in Patients with Advanced Primary Hyperoxaluria Type 1
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.